Palladium deposited on kieselguhr (Pd/K) will be used for several applications in the Replacement Tritium Facility (RTF). The Pd/K procured for the RTF consists of three batches. All three batches meet the specified particle size distribution that 80 weight percent be between 30 and 50 mesh. One batch contains 53.6% palladium which is less than the specified minimum of 55%. Another batch has a chlorine content of 311 ppm which is slightly in excess of the specified maximum of 250 ppm. These nonconformances are not considered significant since batches will be blended to yield Pd/K for the RTF that meets the chlorine specification and has acceptable palladium content. Some of the Pd/K procured for the RTF will be heat treated to strengthen the particles against breakdown during use. Heat treating parameters must be determined that will preserve the desired absorption/desorption behavior of the Pd/K. 8 refs., 7 figs., 2 tabs.

Palladium deposited on kieselguhr (Pd/K) will be used for several applications in the Replacement Tritium Facility (RTF). The Pd/K procured for the RTF consists of three batches. All three batches meet the specified particle size distribution that 80 weight percent be between 30 and 50 mesh. One batch contains 53.6% palladium which is less than the specified minimum of 55%. Another batch has a chlorine content of 311 ppm which is slightly in excess of the specified maximum of 250 ppm. These nonconformances are not considered significant since batches will be blended to yield Pd/K for the RTF that meets the chlorine specification and has acceptable palladium content. Some of the Pd/K procured for the RTF will be heat treated to strengthen the particles against breakdown during use. Heat treating parameters must be determined that will preserve the desired absorption/desorption behavior of the Pd/K. 8 refs., 7 figs., 2 tabs.

Document issued by the Office of the Attorney General of Texas in Austin, Texas, providing an interpretation of Texas law. It provides the opinion of the Texas Attorney General, Jim Mattox, regarding a legal question submitted for clarification;Construction of the Human Immunodeficiency virus service act ,article 4419b-4 ,V.T.C.S(RQ-1886).